Referencer

• Will the unclear path of biosimilar interchangeability become clearer?

  Louise C. Druedahl

  GABI (Generics And Biosimilars Initiative)

  https://gabionline.net/es/biosimilares/investigacion/will-the-unclear-path-of-biosimilar-interchangeability-become-clearer